Results 141 to 150 of about 1,784,951 (230)

Correction: Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection. [PDF]

BMC Infect Dis
Peretz A, Tkhawkho L, Pastukh N, Brodsky D, Namimi-Halevi C, Nitzan O.   +5 more
europepmc   +1 more source

Association of oral vancomycin prophylaxis with Clostridium difficile infection in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Amir M, Kamal K, Jahangir MA, Faiz M, Mushahid Z, Khokhar MM, Wasim A, Sarmad M, Mehboob AU, Anwar MM, Maaz M, Amjad MH, Haris HM, Awais MN, Hassan A.   +14 more
europepmc   +1 more source

Emerging therapies for Clostridium difficile infection – focus on fidaxomicin

, 2013
Fredy Chaparro-Rojas, Kathleen M MullaneDepartment of Medicine, Section of Infectious Diseases, University of Chicago, Chicago, IL, USAAbstract: The epidemiology of Clostridium difficile infections (CDI) has evolved during the last decades, with an ...
Mullane KM, Chaparro-Rojas F
core  

A multifunctional probiotic co-delivery platform for the treatment of Clostridium difficile infection. [PDF]

J Control Release
Yang H, Kuang Y, Wang L, Zhang H, Zhang R, Dai Y, Villafuerte Gálvez JA, Yao J, Liu S, Chen X, Cao Y.   +10 more
europepmc   +1 more source

Surveillance, diagnosis and management of Clostridium Difficile Infection in Ireland update of 2008 guidance

, 2013
Summary Clostridium difficile infection (CDI) results in a wide spectrum of illness ranging from mild diarrhoea to severe colitis. CDI is associated with receiving healthcare and antibiotic use.
Clostridium difficile Sub ‐ Committee
core  

Predictors of Clostridium difficile infection after stoma reversal following TaTME surgery. [PDF]

Updates Surg, 2023
Tirelli F, Lorenzon L, Biondi A, Langellotti L, Santoro G, Agnes A, Pezzuto R, Persiani R, D'Ugo D.   +8 more
europepmc   +1 more source

Retraction: Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation. [PDF]

Cureus
Hamza Saeed M, Qamar S, Ishtiaq A, Umaira Khan Q, Atta A, Atta M, Ishtiaq H, Khan M, Saeed MR, Iqbal A.   +9 more
europepmc   +1 more source

Hemophagocytic Lymphohistiocytosis and Clostridium difficile Infection: A Diagnostic Dilemma. [PDF]

Cureus, 2023
Boldig K, Kiamos A, Agrawal A, Reddy P.
europepmc   +1 more source

Microbiota-Based Therapies for Recurrent Clostridium difficile Infection: A Systematic Review of Their Efficacy and Safety. [PDF]

Cureus
Weerakoon S, Avula S, Mandefro BT, Sundara SV, Lu X, Busmail H, Malasevskaia IA.   +6 more
europepmc   +1 more source

Clinical Characteristics and Impact of Clostridium difficile Infection during Treatment of Rifampicin-Susceptible Pulmonary Tuberculosis. [PDF]

Tuberc Respir Dis (Seoul)
Ha SW, Hwang S.
europepmc   +1 more source